CAJ | 학술논문

目的探讨 HBeAg、 HBV DNA、 PreS1-Ag 对乙肝患者的临床意义。方法对216例乙型病毒性肝炎患者HBeAg、 HBV DNA、 PreS1-Ag进行监测并加以临床分析。结果 PreS1-Ag、 HBeAg与 HBV DNA的阳性率分别为59.3%、42.6%、55.6%。 PreS1-Ag阳性率高于HBeAg阳性率， PreS1-Ag、 HBV DNA的阳性率两者经卡方检验比较差异无显著性。结论 PreS1-Ag是一个很好的反映HBV复制的指标。
목적탐토 HBeAg、 HBV DNA、 PreS1-Ag 대을간환자적림상의의。방법대216례을형병독성간염환자HBeAg、 HBV DNA、 PreS1-Ag진행감측병가이림상분석。결과 PreS1-Ag、 HBeAg여 HBV DNA적양성솔분별위59.3%、42.6%、55.6%。 PreS1-Ag양성솔고우HBeAg양성솔， PreS1-Ag、 HBV DNA적양성솔량자경잡방검험비교차이무현저성。결론 PreS1-Ag시일개흔호적반영HBV복제적지표。
Objective To explore the clinical significance of PreS1-Ag, HBV DNA and HBeAg to hepatitis B patients. Methods PreS1-Ag, HBV DNA and HBeAg in 216 hepatitis B patients were measured and clinically analyzed. Results The positive rates of PreS1-Ag, HBV DNA and HBeAg were 59.3%, 42.6%, 55.6% respectively. PreS1-Ag's positive rates was higher than that of HBeAg. The positive rates of PreS1-Ag and HBV DNA were of no significant difference. Conclusion PreS1-Ag was a good indicator of HBV replication.